- Home
- SNAX vs SLXN Comparison
SNAX vs SLXN Comparison
Compare SNAX & SLXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNAX
- SLXN
- Stock Information
- Founded
- SNAX 2017
- SLXN 2008
- Country
- SNAX United States
- SLXN Israel
- Employees
- SNAX N/A
- SLXN N/A
- Industry
- SNAX Packaged Foods
- SLXN
- Sector
- SNAX Consumer Staples
- SLXN
- Exchange
- SNAX Nasdaq
- SLXN NYSE
- Market Cap
- SNAX 3.5M
- SLXN 3.0M
- IPO Year
- SNAX N/A
- SLXN N/A
- Fundamental
- Price
- SNAX $0.93
- SLXN $0.21
- Analyst Decision
- SNAX
- SLXN Strong Buy
- Analyst Count
- SNAX 0
- SLXN 1
- Target Price
- SNAX N/A
- SLXN $1.00
- AVG Volume (30 Days)
- SNAX 266.6K
- SLXN 1.5M
- Earning Date
- SNAX 11-13-2024
- SLXN 11-14-2024
- Dividend Yield
- SNAX N/A
- SLXN N/A
- EPS Growth
- SNAX N/A
- SLXN N/A
- EPS
- SNAX N/A
- SLXN N/A
- Revenue
- SNAX $19,364,444.00
- SLXN N/A
- Revenue This Year
- SNAX $38.33
- SLXN N/A
- Revenue Next Year
- SNAX N/A
- SLXN N/A
- P/E Ratio
- SNAX N/A
- SLXN N/A
- Revenue Growth
- SNAX N/A
- SLXN N/A
- 52 Week Low
- SNAX $0.75
- SLXN $0.21
- 52 Week High
- SNAX $3.45
- SLXN $13.56
- Technical
- Relative Strength Index (RSI)
- SNAX 46.55
- SLXN N/A
- Support Level
- SNAX $0.75
- SLXN N/A
- Resistance Level
- SNAX $0.96
- SLXN N/A
- Average True Range (ATR)
- SNAX 0.09
- SLXN 0.00
- MACD
- SNAX 0.03
- SLXN 0.00
- Stochastic Oscillator
- SNAX 57.87
- SLXN 0.00
About SNAX Stryve Foods Inc.
Stryve Foods Inc is a healthy snacking company that manufactures, markets, and sells differentiated healthy snacking products. The company offers convenient snacks that are lower in sugar and carbohydrates and higher in protein than other snacks.
About SLXN BIOMOTION SCIENCES
Silexion Therapeutics Corp is a developmental-stage company dedicated to the development of treatments for pancreatic cancer. The company is focused on enhancing its first-generation product (LODERTM ) to develop a newly formulated product to improve the clinical efficacy against pancreatic cancer.